Effect of pelvic artery embolization for postpartum hemorrhage on subsequent pregnancies: a single-center retrospective cohort study

Pelvic artery embolization (PAE) is a uterus-saving treatment for postpartum hemorrhage (PPH); however, subfertility or abnormal placentation for subsequent pregnancy has been a concern in several previous reports. This study aimed to investigate the impact of PAE on subsequent pregnancies in women...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of maternal-fetal & neonatal medicine 2024-12, Vol.37 (1), p.2296360-2296360
Hauptverfasser: Lee, Kyong-No, Kim, Min Kyung, Choi, Bo Young, Lee, Guy Mok, Kim, Hyeon Ji, Park, Jee Yoon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2296360
container_issue 1
container_start_page 2296360
container_title The journal of maternal-fetal & neonatal medicine
container_volume 37
creator Lee, Kyong-No
Kim, Min Kyung
Choi, Bo Young
Lee, Guy Mok
Kim, Hyeon Ji
Park, Jee Yoon
description Pelvic artery embolization (PAE) is a uterus-saving treatment for postpartum hemorrhage (PPH); however, subfertility or abnormal placentation for subsequent pregnancy has been a concern in several previous reports. This study aimed to investigate the impact of PAE on subsequent pregnancies in women with a history of PPH. A retrospective cohort study was conducted on women transferred to the tertiary center for PPH and delivered for the next pregnancy at the same center later. The study group was divided into two groups based on PAE application to treat previous PPH. Of the 62 women included, 66% (41/62) had received PAE for the previous PPH, while 21 had not. Pregnancy outcomes for subsequent pregnancies were compared between the PAE and non-PAE groups. The PAE group had a higher estimated blood loss volume for the present delivery than the non-PAE group (600 vs. 300 mL,  = 0.008). The PAE group also demonstrated a higher incidence of placenta previa (4.8% vs. 24.4%,  = 0.080) and placenta accreta (0% vs. 14.6%,  = 0.082) than the non-PAE group, although the difference was not statistically significant. These findings suggest that the use of PAE to treat PPH may increase the risk of bleeding, placenta previa, and placenta accreta spectrum in subsequent pregnancies.
doi_str_mv 10.1080/14767058.2023.2296360
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2906178484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2906178484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c304t-733ad6818ad16370f178962475f3902de04a8a40db173b825b4eb609fa6ba1a03</originalsourceid><addsrcrecordid>eNo9UctOxDAMjBCI9yeAcuTSxXk0TbkhxEtC4gLnKm2d3aK2KUmKtJz5cLJil5Mtz9gz8hBywWDBQMM1k4UqINcLDlwsOC-VULBHjjfzTJa53N_2G9IROQnhA4AzCfkhORKaScUKdUx-7q3FJlJn6YT9V9dQ4yP6NcWhdn33bWLnRmqdp5MLcUrgPNAVDs77lVkiTWCY64CfM46RTh6XoxmbDsMNNTR047LHrEkQeuoxehempNZ9IW3cyvlIQ5zb9Rk5sKYPeL6tp-T94f7t7il7eX18vrt9yRoBMmaFEKZVmmnTMiUKsKzQpeKyyK0ogbcI0mgjoa1ZIWrN81piraC0RtWGGRCn5Orv7uRdMhxiNXShwb43I7o5VLyE9BUttUzU_I_aJM_Bo60m3w3GrysG1SaAahdAtQmg2gaQ9i63EnM9YPu_tfu4-AUljIO8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2906178484</pqid></control><display><type>article</type><title>Effect of pelvic artery embolization for postpartum hemorrhage on subsequent pregnancies: a single-center retrospective cohort study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Taylor &amp; Francis (Open access)</source><creator>Lee, Kyong-No ; Kim, Min Kyung ; Choi, Bo Young ; Lee, Guy Mok ; Kim, Hyeon Ji ; Park, Jee Yoon</creator><creatorcontrib>Lee, Kyong-No ; Kim, Min Kyung ; Choi, Bo Young ; Lee, Guy Mok ; Kim, Hyeon Ji ; Park, Jee Yoon</creatorcontrib><description>Pelvic artery embolization (PAE) is a uterus-saving treatment for postpartum hemorrhage (PPH); however, subfertility or abnormal placentation for subsequent pregnancy has been a concern in several previous reports. This study aimed to investigate the impact of PAE on subsequent pregnancies in women with a history of PPH. A retrospective cohort study was conducted on women transferred to the tertiary center for PPH and delivered for the next pregnancy at the same center later. The study group was divided into two groups based on PAE application to treat previous PPH. Of the 62 women included, 66% (41/62) had received PAE for the previous PPH, while 21 had not. Pregnancy outcomes for subsequent pregnancies were compared between the PAE and non-PAE groups. The PAE group had a higher estimated blood loss volume for the present delivery than the non-PAE group (600 vs. 300 mL,  = 0.008). The PAE group also demonstrated a higher incidence of placenta previa (4.8% vs. 24.4%,  = 0.080) and placenta accreta (0% vs. 14.6%,  = 0.082) than the non-PAE group, although the difference was not statistically significant. These findings suggest that the use of PAE to treat PPH may increase the risk of bleeding, placenta previa, and placenta accreta spectrum in subsequent pregnancies.</description><identifier>ISSN: 1476-7058</identifier><identifier>EISSN: 1476-4954</identifier><identifier>DOI: 10.1080/14767058.2023.2296360</identifier><identifier>PMID: 38146176</identifier><language>eng</language><publisher>England</publisher><subject>Arteries ; Female ; Humans ; Pelvis ; Placenta Accreta - epidemiology ; Placenta Accreta - therapy ; Placenta Previa ; Postpartum Hemorrhage - epidemiology ; Postpartum Hemorrhage - therapy ; Pregnancy ; Retrospective Studies</subject><ispartof>The journal of maternal-fetal &amp; neonatal medicine, 2024-12, Vol.37 (1), p.2296360-2296360</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c304t-733ad6818ad16370f178962475f3902de04a8a40db173b825b4eb609fa6ba1a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38146176$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Kyong-No</creatorcontrib><creatorcontrib>Kim, Min Kyung</creatorcontrib><creatorcontrib>Choi, Bo Young</creatorcontrib><creatorcontrib>Lee, Guy Mok</creatorcontrib><creatorcontrib>Kim, Hyeon Ji</creatorcontrib><creatorcontrib>Park, Jee Yoon</creatorcontrib><title>Effect of pelvic artery embolization for postpartum hemorrhage on subsequent pregnancies: a single-center retrospective cohort study</title><title>The journal of maternal-fetal &amp; neonatal medicine</title><addtitle>J Matern Fetal Neonatal Med</addtitle><description>Pelvic artery embolization (PAE) is a uterus-saving treatment for postpartum hemorrhage (PPH); however, subfertility or abnormal placentation for subsequent pregnancy has been a concern in several previous reports. This study aimed to investigate the impact of PAE on subsequent pregnancies in women with a history of PPH. A retrospective cohort study was conducted on women transferred to the tertiary center for PPH and delivered for the next pregnancy at the same center later. The study group was divided into two groups based on PAE application to treat previous PPH. Of the 62 women included, 66% (41/62) had received PAE for the previous PPH, while 21 had not. Pregnancy outcomes for subsequent pregnancies were compared between the PAE and non-PAE groups. The PAE group had a higher estimated blood loss volume for the present delivery than the non-PAE group (600 vs. 300 mL,  = 0.008). The PAE group also demonstrated a higher incidence of placenta previa (4.8% vs. 24.4%,  = 0.080) and placenta accreta (0% vs. 14.6%,  = 0.082) than the non-PAE group, although the difference was not statistically significant. These findings suggest that the use of PAE to treat PPH may increase the risk of bleeding, placenta previa, and placenta accreta spectrum in subsequent pregnancies.</description><subject>Arteries</subject><subject>Female</subject><subject>Humans</subject><subject>Pelvis</subject><subject>Placenta Accreta - epidemiology</subject><subject>Placenta Accreta - therapy</subject><subject>Placenta Previa</subject><subject>Postpartum Hemorrhage - epidemiology</subject><subject>Postpartum Hemorrhage - therapy</subject><subject>Pregnancy</subject><subject>Retrospective Studies</subject><issn>1476-7058</issn><issn>1476-4954</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UctOxDAMjBCI9yeAcuTSxXk0TbkhxEtC4gLnKm2d3aK2KUmKtJz5cLJil5Mtz9gz8hBywWDBQMM1k4UqINcLDlwsOC-VULBHjjfzTJa53N_2G9IROQnhA4AzCfkhORKaScUKdUx-7q3FJlJn6YT9V9dQ4yP6NcWhdn33bWLnRmqdp5MLcUrgPNAVDs77lVkiTWCY64CfM46RTh6XoxmbDsMNNTR047LHrEkQeuoxehempNZ9IW3cyvlIQ5zb9Rk5sKYPeL6tp-T94f7t7il7eX18vrt9yRoBMmaFEKZVmmnTMiUKsKzQpeKyyK0ogbcI0mgjoa1ZIWrN81piraC0RtWGGRCn5Orv7uRdMhxiNXShwb43I7o5VLyE9BUttUzU_I_aJM_Bo60m3w3GrysG1SaAahdAtQmg2gaQ9i63EnM9YPu_tfu4-AUljIO8</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Lee, Kyong-No</creator><creator>Kim, Min Kyung</creator><creator>Choi, Bo Young</creator><creator>Lee, Guy Mok</creator><creator>Kim, Hyeon Ji</creator><creator>Park, Jee Yoon</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Effect of pelvic artery embolization for postpartum hemorrhage on subsequent pregnancies: a single-center retrospective cohort study</title><author>Lee, Kyong-No ; Kim, Min Kyung ; Choi, Bo Young ; Lee, Guy Mok ; Kim, Hyeon Ji ; Park, Jee Yoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c304t-733ad6818ad16370f178962475f3902de04a8a40db173b825b4eb609fa6ba1a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Arteries</topic><topic>Female</topic><topic>Humans</topic><topic>Pelvis</topic><topic>Placenta Accreta - epidemiology</topic><topic>Placenta Accreta - therapy</topic><topic>Placenta Previa</topic><topic>Postpartum Hemorrhage - epidemiology</topic><topic>Postpartum Hemorrhage - therapy</topic><topic>Pregnancy</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Kyong-No</creatorcontrib><creatorcontrib>Kim, Min Kyung</creatorcontrib><creatorcontrib>Choi, Bo Young</creatorcontrib><creatorcontrib>Lee, Guy Mok</creatorcontrib><creatorcontrib>Kim, Hyeon Ji</creatorcontrib><creatorcontrib>Park, Jee Yoon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of maternal-fetal &amp; neonatal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Kyong-No</au><au>Kim, Min Kyung</au><au>Choi, Bo Young</au><au>Lee, Guy Mok</au><au>Kim, Hyeon Ji</au><au>Park, Jee Yoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of pelvic artery embolization for postpartum hemorrhage on subsequent pregnancies: a single-center retrospective cohort study</atitle><jtitle>The journal of maternal-fetal &amp; neonatal medicine</jtitle><addtitle>J Matern Fetal Neonatal Med</addtitle><date>2024-12</date><risdate>2024</risdate><volume>37</volume><issue>1</issue><spage>2296360</spage><epage>2296360</epage><pages>2296360-2296360</pages><issn>1476-7058</issn><eissn>1476-4954</eissn><abstract>Pelvic artery embolization (PAE) is a uterus-saving treatment for postpartum hemorrhage (PPH); however, subfertility or abnormal placentation for subsequent pregnancy has been a concern in several previous reports. This study aimed to investigate the impact of PAE on subsequent pregnancies in women with a history of PPH. A retrospective cohort study was conducted on women transferred to the tertiary center for PPH and delivered for the next pregnancy at the same center later. The study group was divided into two groups based on PAE application to treat previous PPH. Of the 62 women included, 66% (41/62) had received PAE for the previous PPH, while 21 had not. Pregnancy outcomes for subsequent pregnancies were compared between the PAE and non-PAE groups. The PAE group had a higher estimated blood loss volume for the present delivery than the non-PAE group (600 vs. 300 mL,  = 0.008). The PAE group also demonstrated a higher incidence of placenta previa (4.8% vs. 24.4%,  = 0.080) and placenta accreta (0% vs. 14.6%,  = 0.082) than the non-PAE group, although the difference was not statistically significant. These findings suggest that the use of PAE to treat PPH may increase the risk of bleeding, placenta previa, and placenta accreta spectrum in subsequent pregnancies.</abstract><cop>England</cop><pmid>38146176</pmid><doi>10.1080/14767058.2023.2296360</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1476-7058
ispartof The journal of maternal-fetal & neonatal medicine, 2024-12, Vol.37 (1), p.2296360-2296360
issn 1476-7058
1476-4954
language eng
recordid cdi_proquest_miscellaneous_2906178484
source MEDLINE; Alma/SFX Local Collection; Taylor & Francis (Open access)
subjects Arteries
Female
Humans
Pelvis
Placenta Accreta - epidemiology
Placenta Accreta - therapy
Placenta Previa
Postpartum Hemorrhage - epidemiology
Postpartum Hemorrhage - therapy
Pregnancy
Retrospective Studies
title Effect of pelvic artery embolization for postpartum hemorrhage on subsequent pregnancies: a single-center retrospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A07%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20pelvic%20artery%20embolization%20for%20postpartum%20hemorrhage%20on%20subsequent%20pregnancies:%20a%20single-center%20retrospective%20cohort%20study&rft.jtitle=The%20journal%20of%20maternal-fetal%20&%20neonatal%20medicine&rft.au=Lee,%20Kyong-No&rft.date=2024-12&rft.volume=37&rft.issue=1&rft.spage=2296360&rft.epage=2296360&rft.pages=2296360-2296360&rft.issn=1476-7058&rft.eissn=1476-4954&rft_id=info:doi/10.1080/14767058.2023.2296360&rft_dat=%3Cproquest_cross%3E2906178484%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2906178484&rft_id=info:pmid/38146176&rfr_iscdi=true